Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion type Assertion NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_head.
- NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion description "[Finally, we comment on the importance of recent advances in TDP-43-related research to neurological practice, including the new opportunities to develop better diagnostics and disease-modifying therapies for ALS, FTLD-TDP, and related disorders exhibiting TDP-43 pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_provenance.
- NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion evidence source_evidence_literature NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_provenance.
- NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion SIO_000772 20234357 NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_provenance.
- NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion wasDerivedFrom befree-2016 NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_provenance.
- NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_assertion wasGeneratedBy ECO_0000203 NP800393.RA-1f7pa10OFwsqnYQJE9fVGrTbw4PLomrm9WlzQxsR4k130_provenance.